自民國73年1月至75年10月曾經在榮總眼科接受治療之內因性葡萄膜炎計291名。其中男性214名,女性77名。291名病人中榮民占91名(31.3%)。葡萄膜炎的類型為:HLA-B27類型關連性葡萄膜炎118名(40.5%)、貝西氏病43名(14.8%)、原田氏病及交感性眼炎29名(10.0%)、周邊性葡萄膜炎12名(4.1%)、病毒感染性葡萄膜炎11名(3.8%)、Fuchs'虹彩異色性睫狀體炎6名(2.1%)、梅毒性5名、晶體性3名、葡萄膜炎假面症候群2名、急性網膜壞死症2名、偽晶體性2名、結核病性2名、痳瘋病性2名、類肉瘤症1名、後發性多發性軟骨炎1名及糖尿病性1名。無法歸類者51名(17.5%),其中24名的臨床表現為急性前葡萄膜炎而HLA-B27抗原為陰性。HLA-B27類型關連性葡萄膜炎的平均罹病年齡為38.2±14.9歲,貝西氏病的為32.4±8.9歲,原田氏病的為39.1±16.5歲而周邊性葡萄膜炎的為39.1±13.1歲。兩眼被波及者在貝西氏病有95.3%,在HLA-B27類型關連性葡萄膜炎有49.2%,在HLA-B27陰性急性前葡萄膜炎有41.7%而在周邊性葡萄膜炎有33.3%。被波及之眼中貝西氏病有92.9%的後發率,HLA-B27類型關連性葡萄膜炎有74.4%而HLA-B27陰性急性前葡萄膜炎有67.6%。後發率在貝西氏病最常小於或等於3個月,在HLA-B27類型關連性葡萄膜炎較常半年到1年半間而在HLA-B27陰性急性前葡萄膜較常大於3年。HLA-B27類型關連性葡萄膜炎經過平均8.9年後84.8%的患眼有大於或等於0.5的視力而原田氏病經3.6年有60.9%,周邊性葡萄膜炎經1.9年有43.8%有大於或等於0.5的視力。貝西氏病則經過平均4.2年有51.8%的患眼有小於或等於0.1的視力。
From January 1984 to October 1986, totally 291 patients of endogenous uveitis were treated at the Veterans General Hospital. There were 214 males and 77 females and 91 (31.3%) of them were veterans. The 291 patients consisted of 118 (40.5%) of HLA-B27-positive AAU, 43 (14.8%) of Behcet's disease, 29(10.0%) of Harada's disease and sympathetic ophthalmia, 12 (4.1%) of peripheral uveitis, 11 (3.8%) of the virus-induced, 6 (2.1%) of Fuchs' heterochromic cyclitis, 5 of syphilis, 3 of the lens-induced, 2 of masquerade syndrome, 2 of acute retinal necrosis, 2 of the pseudophakic, 2 of tuberculosis, 2 of leprosy, 1 of sarcoidosis, 1 of relapsing polychondritis, 1 of the diabetic and 51 (17.5%) of undetermined group. 24 of the undetermined group manifested as AAU and had no HLA-B27 antigen. Average age of onset was 38.2±14.9 of HLA-B27 associated AAU, 32.4±8.9 of Behçet's disease, 39.1± 16.5 of Harada's disease and 39.1± 13.1 of peripheral uveitis. 95.3% of patients of Behçet's disease, 49.2% of HLA-B27-positive AAU, 41.7% of HLA-B27-negative AAU and 33.3% of peripheral uveitis were involved bilaterally. 92.9% of involved eyes of Behçet's, disease, 74.4% of HLA-B27- positive AAU and 67.6% of HLA-B27-negative AAU showed recurrence. Uveitis in Behçet's disease recurred most often once equal to or less than three months, HLA-B27-positive AAU more often half to one and a half year and HLAB27-negative AAU more often more than three years. 84.8% of involved eyes of HLA-B27-positive AAU, 60.9% of Harada's disease and 43.8% of peripheral uveitis had visual acuity equal to or better than 0.5 after an average of 8.9, 3.6, and 1 .9 years respectively. However, after an average of 4.2 years, 51.8% of involved eyes of Behçet's disease had visual acuity equal to or less than 0.1.